Patent details
LUC00236 Product Name: Apalutamide
Basic Information
- Publication number:
- LUC00236
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP191692755
- Legal Status:
- Inactive
- Application number:
- LUC00236
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/18/1342
- Marketing Authorization Type:
- Marketing Authorization Date:
- 16/01/2019
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 02/11/2021
- First Marketing Authorization date:
- 16/01/2019
- Grant date:
- 03/02/2025
- Activation date:
- Publication date:
- 02/11/2021
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 16/01/2034
- SPC Extension Expiration:
- 16/01/2034
- Rejection date:
- Withdrawal date:
Owner
- From:
- 02/09/2022
- Name:
- Aragon Pharmaceuticals, Inc.
- Address:
- 10990 Wilshire Blvd. Suite 440, CA90024, Los Angeles, California, United States (US)
- From:
- 02/11/2021
- Name:
- Sloan Kettering Institute For Cancer Research
- Address:
- 1275 York Avenue, New York, NY 10065, United States (US)
History of Owners
- From:
- 02/11/2021
- To:
- 02/09/2022
- Name:
- Aragon Pharmaceuticals, Inc.
- Address:
- 10990 Wilshire Blvd. Suite 300, Los Angeles, CA 90024, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 02/11/2021
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2022/11
- Publication date:
- 04/10/2022
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
2
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2021/13
- Publication date:
- 02/12/2021
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
3
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2025/04
- Publication date:
- 04/03/2025
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name/address
- Deed Number:
- RC20220000350A
- Date Registered:
- 02/09/2022
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- change of owners address
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
1
- Name:
- Sloan Kettering Institute For Cancer Research
- Address:
- 1275 York Avenue, New York, NY 10065, United States (US)
2
- Name:
- Aragon Pharmaceuticals, Inc.
- Address:
- 10990 Wilshire Blvd. Suite 440, CA90024, Los Angeles, United States (US)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 30/06/2033
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 02/11/2021 | Marketing authorization | 3 |
| 02/11/2021 | Summary of the product caracteristics | 43 |
| 02/11/2021 | Outgoing Correspondence | 1 |
| 02/11/2021 | Application Form | 3 |
| 02/11/2021 | MA publication | 10 |
| 02/09/2022 | Request For Change | 1 |
| 02/09/2022 | Outgoing Correspondence | 1 |
| 02/11/2021 | Publication | 1 |
| 03/02/2025 | Publication | 1 |
| 03/02/2025 | Certificate | 1 |
| 03/02/2025 | Outgoing Correspondence | 1 |